Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 31: 142-146, 1985;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Leenheer, A. P.
Right arrow Articles by Bauwens, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Leenheer, A. P.
Right arrow Articles by Bauwens, R. M.

Clinical Chemistry, Vol 31, 142-146, Copyright © 1985 by American Association for Clinical Chemistry

Radioimmunoassay for 1,25-dihydroxyvitamin D in serum or plasma

AP De Leenheer and RM Bauwens

For this sensitive RIA for 1 alpha,25-dihydroxyvitamin D, we used antibodies to 1 alpha,25-dihydroxycholecalciferol-3-hemisuccinate conjugated to bovine serum albumin, raised in rabbits. These antibodies show a high affinity for 1 alpha,25-dihydroxyvitamin D3 but cross react with other vitamin D metabolites as well. Extraction and liquid chromatography are required to isolate the 1 alpha,25-dihydroxyvitamin D from human serum or plasma with benzene (analytical recovery, 96%) and chromatographed by "high-performance" liquid chromatography on a silica column. The sensitivity of the assay is 2 pg/tube. The between- assay CV is 12.6% (means = 61.8 ng/L, n = 27) and the within-assay CV is 7.4% (means = 61.8 ng/L, n = 15). The reference interval, obtained from data on serum of healthy persons, is 51.8 +/- 15.1 ng/L (means +/- SD, n = 91), with no sex-related difference. Patients with chronic renal failure have lower concentrations in serum, and patients suffering from calcium nephrolithiasis have increased concentrations. Our assay offers the advantage of a relatively short prepurification procedure and the production of large amounts of stable gamma-globulins that can be used for several years without loss of binding properties.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Association for Clinical Chemistry.